Open AccessMultilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case)
Author(s) -
А. Ф. Насретдинов,
А. В. Пушкарев,
Oleg Lipatov,
Н. И. Султанбаева,
Ш. И. Мусин,
К. V. Menshikov,
А. А. Измайлов,
В. А. Пушкарев,
М Г Галеев,
R. R. Muginov,
Р. Б. Валиахмедов,
Dina Sakaeva,
А. В. Султанбаев
Publication year - 2021
Publication title -
opuholi ženskoj reproduktivnoj sistemy
Language(s) - English
Resource type - Journals
eISSN - 1999-8627
pISSN - 1994-4098
DOI - 10.17650/1994-4098-2021-17-1-35-44
Subject(s) - medicine , metastatic breast cancer , oncology , clinical trial , breast cancer , disease , trastuzumab , cancer , intensive care medicine
Descripton of metastatic HER2-positive breast cancer clinical case is introduced, multilineal strategy basing on clinical situation and disease features is justified, justification of the choice of anti-HER2 treatment in every line is made, in compliance with russian and foreigh oncology associations guidelines, along with comparance of rutine treatment results and randomised trials data.